Investing in a more resilient and efficient supply chain
Cencora is investing $1 billion through 2030 to expand and strengthen our pharmaceutical distribution network in the United States. This investment reflects our commitment to build a more resilient and efficient supply chain: one that meets our customers’ growing needs and helps to ensure patients have timely and reliable access to their prescribed medications. By enhancing our infrastructure and digital capabilities, we’re positioning our customers to operate with greater confidence, agility, and access to the therapies their patients depend on.
Change is inevitable—We can help you face the headwinds.
As 340B industry shifts continue, from administrative announcements to legislative rulings, and contractual navigations, we can help you analyze program impact and streamline your procedures. Our Accelerated Pharmacy Solutions 340B Consultants are here to help you optimize your program, stay compliant, and plan for the future—whatever it may bring. Visit our website to learn more about the team’s expertise and the solutions they can support you.
